MTOR and breast cancer: Reprogramming experiments on MCF-7 human breast cancer using iPSCs technology to establish an in vitro model of the CSCs-like state revealed that transcriptional repression of mTOR blockers is an intrinsic process that occurs during the acquisition of CSCs-like properties in differentiated breast cancer cell populations [88].